azoxymethane has been researched along with fucoxanthin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, H; Kubota, A; Maeda, H; Miyashita, K; Mutoh, M; Ogasa, S; Sano, T; Tanaka, T; Terasaki, M; Uehara, O | 1 |
| Hashimoto, S; Kojima, H; Kubota, A; Maeda, H; Miyashita, K; Mutoh, M; Ohta, T; Ono, S; Tanaka, T; Terasaki, M | 1 |
| Kamakura, Y; Kawakami, S; Kojima, H; Kubota, A; Maeda, H; Miyashita, K; Murase, W; Mutoh, M; Ohta, T; Tanaka, T; Terasaki, M | 1 |
3 other study(ies) available for azoxymethane and fucoxanthin
| Article | Year |
|---|---|
Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice.
Topics: Adenocarcinoma; Animals; Azoxymethane; Colitis-Associated Neoplasms; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Screening Assays, Antitumor; Feces; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Male; Mice; Xanthophylls | 2021 |
Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin.
Topics: Animals; Azoxymethane; Chemokines, CC; Colonic Neoplasms; Cyclin D1; Dextran Sulfate; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred ICR; Proto-Oncogene Proteins c-akt; Receptors, CCR1; Smad2 Protein; Xanthophylls | 2022 |
A Biscuit Containing Fucoxanthin Prevents Colorectal Carcinogenesis in Mice.
Topics: Animals; Azoxymethane; Carcinogenesis; Colitis; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Humans; Mice; Xanthophylls | 2022 |